University College London (UCL) is a core academic partner of the COG-UK consortium. The COG-UK Hospital Onset COVID-19 Infection (HOCI) study is led by UCL — which is investigating how integrating rapid, real-time COVID-19 genomic sequencing can impact decision-making by infection control teams to prevent the spread of the SARS-CoV-2 virus in NHS hospitals. The team have been working in joint partnership with Virology at Imperial College Healthcare NHS Trust, Dr David Muir and Dr Paul Rendell.
Contributors:
Leading the sequencing initiative at UCL are:
- Professor Judith Breuer, Professor of Virology and Co-Director of the Division of Infection and Immunity at UCL and Consultant Clinical Virologist at Great Ormond Street Hospital for Children [GoogleScholar] [ORCID] [Profile]
- Dr Rachel Williams, Head of Sequencing, UCL Genomics [LinkedIN]
- Dr Sunando Roy, Research Associate in Bioinformatics [LinkedIN] [Profile] [Researchgate]
- Charlotte Williams, Research Assistant, Sequencing [LinkedIN] [Profile]
- Nadua Bayzid, Research Assistant, Sequencing
- Marius Cotic, Research Assistant, Sequencing
- Rose Gkouleli, Research Assistant, Sequencing
- Helena Tutill, Senior Research Technician [LinkedIN] [Researchgate]
- Patricia Dyal Bynoe, Research Technician
- Dr Jose Afonso Guerra-Assuncao, Research Fellow, Bioinformatics
- Dr Florencia Tettamanti Boshier, Research Fellow, Bioinformatics
- UCL Genomics team
